BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
29 hedge funds and large institutions have $7.1M invested in Bellicum Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-22
Holders Change %
-43.14%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
12
Closed
27
Calls
$2.41M
Puts
$105K
Net Calls
+$2.3M
Net Calls Change
+$2.02M
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$89K |
| 2 |
Morgan Stanley
New York
|
+$87.6K |
| 3 |
Millennium Management
New York
|
+$77K |
| 4 |
SCM
Sio Capital Management
New York
|
+$58K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$57.1K |
